KFDA to approve an oral quit-smoking remedy, Champix.
Published: 2007-04-04 06:57:00
Updated: 2007-04-04 06:57:00
The KFDA announced an approval of Champix (varenicline tartrate), an oral quit-smoking remedy as of March 30 filed by Pfizer Korea based on the clinical study evidences of showing 60% success in quitting smoking. Now, Champix may trigger a hot competition on the market.
At present, the quit-s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
